Cutaneous Microdialysis: Cytokine Evidence for Altered Innate Reactivity in the Skin of Psoriasis Patients?
Journal Title: The AAPS Journal - Year 2012, Vol 14, Issue 2
Abstract
The online version of this article (doi:10.1208/s12248-012-9331-z) contains supplementary material, which is available to authorized users.
Authors and Affiliations
Florence Sjögren, Karin Davidsson, Michael Sjöström, Chris D. Anderson
Keywords
Related Articles
- EP ID EP681203
- DOI 10.1208/s12248-012-9331-z
- Views 64
- Downloads 0
Mass Spectrometry-Based Targeted Proteomics as a Tool to Elucidate the Expression and Function of Intestinal Drug Transporters
Intestinal transporter proteins affect the oral bioavailability of many drugs in a significant manner. In order to estimate or predict their impact on oral drug absorption, data on their intestinal expression levels are...
The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-review
Ivermectin is an antiparasitic drug with a broad spectrum of activity, high efficacy as well as a wide margin of safety. Since 1987, this compound has a widespread use in veterinary medicine and it use has been extended...
Activity and kinetics of dissociation and transfer of amphotericin B from a novel delivery form
Recently it has been demonstrated that moderate heat treatment of Amphotericin B/deoxycholate solutions (HAmB-DOC) leads to a therapeutically interesting supramolecular rearrangement that can be observed by significant c...
Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids
The online version of this article (doi:10.1208/s12248-015-9732-x) contains supplementary material, which is available to authorized users.
Pharmacokinetics, mass balance, and tissue distribution of a novel DNA alkylating agent, VNP40101M, in rats
VNP40101M (1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(2 methylamino)carbonyl] hydrazine), a novel DNA alkylating agent, is currently under clinical development for the treatment of cancer in Phase I clinical trials. T...